MarketPeel
Insider Trading Intelligence
BL

Boyan Vesselinov Litchev

INDP
CHIEF MEDICAL OFFICER · INDAPTUS THERAPEUTICS, INC. · CIK 0001902726
FILING MIX · LIFETIME100%/0%
BUYS
5
SELLS
0
TOTAL VALUE
$2.5K
COMPANIES
1
ACTIVE SINCE
Jan 2022
HOLDINGS NOW
1,150
AVG SELL PX
TRADE KIND
SHOWING 5 / 5
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Boyan Vesselinov Litchev, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+25.00%-1.19%-1.72%+0.54%-0.07%
14d4+50.00%-1.78%-2.20%+0.43%+2.04%
30d4+0.00%-13.25%-2.24%-11.01%-11.61%
60d4+0.00%-14.59%-1.46%-13.14%-14.15%
90d4+0.00%-21.05%-3.85%-17.20%-16.92%
180d4+25.00%-18.21%-1.37%-16.84%-20.61%
1y4+50.00%-20.97%+3.55%-24.51%-25.07%
2y4+0.00%-50.33%+34.17%-84.49%-86.47%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
INDP · 1,150 shares · as of Dec 1, 2022
022,50045,00067,50090,000SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2022
2022
FLOW · 5 buys / 0 sellsCOVERAGE · 4 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
INDP
INDAPTUS THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
500$1.87$9351,150Dec 1, 2022Dec 19, 2022View →
INDP
INDAPTUS THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
500$1.83$915650Nov 22, 2022Dec 19, 2022View →
INDP
INDAPTUS THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
50$4.09$205150Mar 2, 2022Dec 19, 2022View →
INDP
INDAPTUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
90,00090,000Feb 1, 2022Feb 2, 2022View →
INDP
INDAPTUS THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
100$4.65$465100Jan 31, 2022Dec 19, 2022View →
Other insiders · INDP
Loading peer insiders…
About this filer
CIK 0001902726
ROLE
Chief Medical Officer
PRIMARY
INDP
COMPANIES
1
ACTIVE SINCE
Jan 2022
MARKETPEEL · /INSIDER/0001902726DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback